Adagene Inc.
ADAGNASDAQHealthcare● Active
$3.57
$-0.01(-0.28%)
Market Cap$134405495
P/E Ratio—
52W High$4.75
52W Low$1.3
Adagene Inc.（ADAG）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ADAG · 截至 2026-06-13
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($17.61M) | ($33.42M) | ($18.95M) | ($79.97M) | ($73.18M) |
| Depreciation & Amort. | $0.59M | $0.93M | $1.21M | $1.45M | $1.13M |
| Stock-Based Comp. | $3.74M | $4.91M | $7.27M | $10.52M | $18.68M |
| Change in Working Capital | ($0.78M) | ($1.89M) | ($16.55M) | $21.94M | $9.35M |
| Net Cash from Operations | ($15.66M) | ($29.70M) | ($28.45M) | ($48.61M) | ($43.41M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.02M) | ($0.03M) | ($0.09M) | ($0.69M) | ($2.51M) |
| Purchases of Investments | ($80.00M) | ($128.50M) | ($47.00M) | $0.00M | $0.00M |
| Sales of Investments | $80.49M | $129.64M | $47.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.48M | $1.11M | ($0.08M) | ($0.69M) | ($2.51M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | ($3.98M) | ($2.36M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($12.24M) | ($3.42M) | ($5.37M) | $21.48M | ($0.70M) |
| Net Cash from Financing | $4.45M | $3.77M | ($5.37M) | $17.82M | $145.36M |
| Free Cash Flow | |||||
| Free Cash Flow | ($15.67M) | ($29.73M) | ($28.54M) | ($49.30M) | ($45.92M) |
| FCF Margin %(computed) | -204.34% | — | -157.58% | -530.55% | -451.34% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-13 · USD · M
深入了解Adagene Inc.
关于Adagene Inc.（ADAG）现金流量表
Adagene Inc. 2025财年经营活动现金流($0.02B)，自由现金流($0.02B)（FCF利润率-204.34%），资本支出($0.00B)。
常见问题
ADAG · 4 问Adagene Inc. 2025财年自由现金流($0.02B)，同比up47.3%。
ADAG free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-13